Texas Retina Associates
Clinical trials sponsored by Texas Retina Associates, explained in plain language.
-
New combo therapy may cut needle pokes for macular degeneration patients
Disease control CompletedThis study tested whether adding a light-activated drug treatment (photodynamic therapy) to the standard injection therapy (ranibizumab) could reduce the number of injections needed for wet macular degeneration. 60 participants aged 50 and older with the condition were enrolled. …
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Combination eye therapy may cut injection frequency for vein occlusion patients
Disease control CompletedThis study looked at whether adding Ozurdex to standard Avastin eye injections can reduce the number of injections needed for people with a blocked vein in the eye (non-ischemic central retinal vein occlusion). 68 adults participated. The main goal was to count how many Avastin i…
Phase: PHASE2, PHASE3 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated May 22, 2026 14:02 UTC